Regeneron (REGN) - Get Report said Monday it had started late-stage clinical trials evaluating Regn-Cov2, the biopharma's double antibody cocktail to treat and prevent coronavirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,